Key facts
- This page summarizes Jean Jacques Bienaime's Form 4 filing for Immunome Inc. (IMNM).
- 5 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 09 Jun 2026, 17:40.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Purchase
Purchase
Purchase
Additional SEC filing notes
Footnote F1
The sales by the reporting person reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase of 1,000 shares of the Issuer's common stock by the reporting person at the price of $19.27 per share on June 5, 2026. The reporting person has agreed to pay to the Issuer upon settlement of the sale, $155, representing the full amount of the profit realized in connection with the short-swing transaction.
Footnote F2
The reporting person sold and reacquired the same aggregate number of shares on June 5, 2026.